<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> disorder that causes premature fusion of the cranial suture </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e>, Pfeiffer, and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndromes</z:e> are caused by mutations in the extracellular, third immunoglobulin-like domain, and adjacent linker regions (exons IIIa and IIIc) of the fibroblast growth factor receptor 2 (FGFR2) gene </plain></SENT>
<SENT sid="2" pm="."><plain>We screened 12 Crouzon syndrome patients for mutations in exons IIIa and IIIc of the FGFR2 gene by polymerase chain reaction (PCR) and direct sequencing </plain></SENT>
<SENT sid="3" pm="."><plain>Mutations were detected in nine of 12 patients at amino acid positions 278, 281, 289, 342, and 354 </plain></SENT>
<SENT sid="4" pm="."><plain>More than half of the studied <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> patients carried a mutation resulting in either the loss or gain of a <z:chebi fb="0" ids="32460">cysteine residue</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>A novel missense Ser354Phe substitution at exon IIIc of the human FGFR2 gene was found </plain></SENT>
<SENT sid="6" pm="."><plain>According to our results, sequencing analysis of IgIII domain of the FGFR2 gene can lead to a genetic diagnosis of <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon syndrome</z:e> </plain></SENT>
</text></document>